{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Organization",
      "@id": "https://virobayinc.com/#organization",
      "name": "ViroBay - leaders in protease inhibitor design",
      "url": "https://virobayinc.com/",
      "description": "ViroBay - leaders in protease inhibitor design Viro bay Discovering the posibilities Download pdf on our company [our team, our approach, our pipeline] Home About Virobay Management team Board of directors Investors Partnering Request Information Pipeline VBY-129 VBY-891 VBY-036 VBY-285 VBY-376 VBY-825 Intellectual Property Research & Development Cathespin Protease Targets Neuropathic Pain Autoimmune Diseases Liver Fibrosis Atherosclerosis Oncology Other Disease Indications Publications and Presentations News Contact Latest Post: What to Expect From Medically Supervised Detox and Dual-Diagnosis Residential Care - 2026-08-04 Enteral Nutrition Support: Safety, Monitoring, and Patient Outcomes"
    },
    {
      "@type": "WebPage",
      "@id": "https://directory.websdocs.com/business/virobay-leaders-in-protease-inhibitor-design#asg",
      "name": "ViroBay - leaders in protease inhibitor design ASG Directory Profile",
      "url": "https://directory.websdocs.com/business/virobay-leaders-in-protease-inhibitor-design",
      "isPartOf": {
        "@id": "https://virobayinc.com/#organization"
      },
      "description": "Public business information published by the WebsDocs ASG Directory."
    }
  ]
}